Roles for the long non-coding RNA Pax6os1/PAX6-AS1 in pancreatic beta cell function.
Lopez-Noriega L., Callingham R., Martinez-Sánchez A., Nawaz S., Pizza G., Haberman N., Cvetesic N., Nguyen-Tu M-S., Lenhard B., Marchetti P., Piemonti L., de Koning E., Shapiro AMJ., Johnson PR., Leclerc I., Hastoy B., Gauthier BR., Pullen TJ., Rutter GA.
Long non-coding RNAs (lncRNAs) are emerging as crucial regulators of beta cell function. Here, we show that an lncRNA-transcribed antisense to Pax6, annotated as Pax6os1/PAX6-AS1, was upregulated by high glucose concentrations in human as well as murine beta cell lines and islets. Elevated expression was also observed in islets from mice on a high-fat diet and patients with type 2 diabetes. Silencing Pax6os1/PAX6-AS1 in MIN6 or EndoC-βH1 cells increased several beta cell signature genes' expression. Pax6os1/PAX6-AS1 was shown to bind to EIF3D, indicating a role in translation of specific mRNAs, as well as histones H3 and H4, suggesting a role in histone modifications. Important interspecies differences were found, with a stronger phenotype in humans. Only female Pax6os1 null mice fed a high-fat diet showed slightly enhanced glucose clearance. In contrast, silencing PAX6-AS1 in human islets enhanced glucose-stimulated insulin secretion and increased calcium dynamics, whereas overexpression of the lncRNA resulted in the opposite phenotype.